| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/23/1995 | WO1995005466A1 Models of alzheimer's disease |
| 02/23/1995 | WO1995005465A1 Erythropoietin analogs |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis |
| 02/23/1995 | WO1995005393A2 Lipopolysaccharide-binding and neutralizing peptides |
| 02/23/1995 | WO1995005392A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
| 02/23/1995 | DE4407538C1 Binding reagent for cell surface protein and effector cell |
| 02/23/1995 | CA2169459A1 Novel proteins which bind to retinoblastoma protein and their encoding dna sequences |
| 02/23/1995 | CA2146667A1 Lipopolysaccharide-binding and neutralizing peptides |
| 02/22/1995 | EP0639643A2 Mutant AOX2 promoter |
| 02/22/1995 | EP0639225A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| 02/22/1995 | EP0639224A1 Lectin domain variants of selectin |
| 02/22/1995 | EP0639202A1 Stable polypeptide composition |
| 02/22/1995 | EP0535060B1 Antifungal polypeptide, process for producing it |
| 02/22/1995 | EP0478659B1 Interferon purification process |
| 02/22/1995 | EP0229829B1 Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein |
| 02/21/1995 | US5391492 A83850 antibiotics |
| 02/21/1995 | US5391485 DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues |
| 02/21/1995 | CA2006144C Microbial process for the production of immunosuppressive antibiotics |
| 02/16/1995 | WO1995004829A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | WO1995004823A1 High molecular weight desulphatohirudin |
| 02/16/1995 | WO1995004822A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | WO1995004821A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 02/16/1995 | WO1995004816A1 Compositions and methods for producing sialyltransferases |
| 02/16/1995 | WO1995004758A1 Monoclonal antibodies to thymidine kinase isozymes |
| 02/16/1995 | WO1995004754A1 Antimicrobial proteins |
| 02/16/1995 | WO1995004744A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | WO1995004548A1 Prostatic cancer vaccine |
| 02/16/1995 | WO1995004542A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | WO1995004521A1 Cell encapsulating device |
| 02/16/1995 | WO1994029472A3 Mengovirus as a vector for expression of foreign polypeptides |
| 02/16/1995 | WO1994029451A3 Humanised antibodies |
| 02/16/1995 | CA2170234A1 Production of human hemoglobin in transgenic pigs |
| 02/16/1995 | CA2168952A1 Prostatic cancer vaccine |
| 02/16/1995 | CA2168582A1 Cloning and characterization of the complete mage-1 gene |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2167489A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 02/16/1995 | CA2166982A1 Human calcium channel compositions and methods using them |
| 02/16/1995 | CA2166309A1 Antimicrobial proteins |
| 02/16/1995 | CA2144523A1 High molecular weight desulphatohirudin |
| 02/15/1995 | EP0638648A2 Monoclonal antibodies specifically reacting with PAF receptor, production process thereof, and hybridomas producing the antibodies |
| 02/15/1995 | EP0638647A1 Nucleotide sequences permitting replication and maintaining of genetic information in animal cells |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638174A1 Measles virus-specific antibody detection using recombinant measles proteins. |
| 02/15/1995 | EP0638172A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF $g(b)-AMYLOID PRECURSOR PROTEIN |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638123A1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0637916A1 Agricultural use of certain compounds, compositions and methods for producing said compounds |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/15/1995 | EP0377023B1 Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 02/15/1995 | CN1098742A Novel aminopeptidase, processes for the preparation of aminopeptidase and protein therefrom |
| 02/14/1995 | US5389609 Antifungal preparations, and process for making such preparations |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389539 Purification of heparinase I, II, and III from Flavobacterium heparinum |
| 02/14/1995 | US5389530 Methods for the production of antibodies and induction of immune responses to tumor-associated ganagliosides by immunization with gangloiside lactones |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389525 DNA-molecules coding for FMDH control regions and structural gene for a protein having FMDH-activity and their use thereof |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/09/1995 | WO1995004282A1 Immunoassay for detecting collagen or collagen fragments |
| 02/09/1995 | WO1995004278A1 Process for labelling immunoglobulins |
| 02/09/1995 | WO1995004151A2 Vaccine compositions containing recombinant tetc-fusion proteins |
| 02/09/1995 | WO1995004150A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 02/09/1995 | WO1995004144A1 Dna encoding a human calcium channel alpha-1e subunit |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004076A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995003831A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | WO1995003825A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/09/1995 | WO1995003820A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003813A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | WO1995003690A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures |
| 02/09/1995 | WO1995000645A3 Process for producing relaxin |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168647A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167730A1 Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof |
| 02/09/1995 | CA2167533A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | CA2167496A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/09/1995 | CA2166995A1 Transgenic, cross-linked hemoglobin |
| 02/08/1995 | EP0637631A2 Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen |
| 02/08/1995 | EP0637630A2 Method for the biological synthesis of peptides |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 02/08/1995 | EP0637336A1 Mn gene and protein |